Artificial intelligence-enabled digital pharmacovigilance system for monitoring global drug safety and side effects reporting, has patient reporting and monitoring node provided with processor board connected with power supply, radio frequency module, IMU sensor, ECG sensor and infrared thermometer
2025-03-29
专利权人UNIV GALGOTIAS (UYGA-Non-standard)
申请日期2025-03-29
专利号IN202511031224-A
成果简介NOVELTY - The system has a patient reporting and monitoring node provided with a Jetson 5 Nano (RTM: Energy-efficient embedded system) processor board (906) connected with a power supply (900), a SX1276 radio frequency (RF) module (901), an IMU sensor (902), an ECG sensor (903), an infrared thermometer (904), and a pulse oximeter (905). The patient reporting and monitoring node enables real-time physiological data acquisition and wireless transmission for ensuring continuous remote monitoring of patient health for drug safety assessment. An adverse event data collection node facilitates secure authentication of prescription for automated adverse event reporting, and seamless data communication to enhance pharmacovigilance accuracy. USE - AI-enabled digital pharmacovigilance system for monitoring global drug safety and side effects reporting of a patient by a healthcare provider, regulatory authority and pharmaceutical company. ADVANTAGE - The system enhances the accuracy, efficiency, and responsiveness of global drug safety monitoring, thus reducing medication-related risks and improving patient outcomes. The system ensures real-time data collection, secure transmission, and intelligent analysis of drug safety concerns by automating adverse event detection and streamlining reporting. The system enhances patient safety and drug efficacy by generating preliminary reports on adverse events, which are reviewed and validated by medical experts to ensure accuracy and patient safety. The system enables seamless remote monitoring of patients in real time since the SX1276 RF module ensures long-range wireless transmission of collected data to the next node. DESCRIPTION OF DRAWING(S) - The drawing shows a block diagram of an AI-enabled digital pharmacovigilance system. 900Power supply 901SX1276 RF module 902IMU sensor 903ECG sensor 904Infrared thermometer 905Pulse oximeter 906Processor board
IPC 分类号A61B-005/00 ; A61B-005/0205 ; A61B-005/1455 ; G16H-050/20 ; G16H-070/40
国家印度
专业领域信息技术
语种英语
成果类型专利
文献类型科技成果
条目标识符http://119.78.100.226:8889/handle/3KE4DYBR/13326
专题中国科学院新疆生态与地理研究所
作者单位
UNIV GALGOTIAS (UYGA-Non-standard)
推荐引用方式
GB/T 7714
YADAV S. Artificial intelligence-enabled digital pharmacovigilance system for monitoring global drug safety and side effects reporting, has patient reporting and monitoring node provided with processor board connected with power supply, radio frequency module, IMU sensor, ECG sensor and infrared thermometer. IN202511031224-A[P]. 2025.
条目包含的文件
条目无相关文件。
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。